Document Detail

Allografts for aortic valve or root replacement: insights from an 18-year single-center prospective follow-up study.
MedLine Citation:
PMID:  17350857     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: Whether allografts are the biological valve of choice for AVR in non-elderly patients remains a topic of debate. In this light we analyzed our ongoing prospective allograft AVR cohort and compared allograft durability with other biological aortic valve substitutes. METHODS: Between April 1987 and October 2005, 336 patients underwent 346 allograft AVRs (95 subcoronary, 251 root replacement). Patient and perioperative characteristics, cumulative survival, freedom from reoperation, and valve-related events were analyzed. Using microsimulation, for adult patients, age-matched actual freedom from allograft reoperation was compared to porcine and pericardial bioprostheses. RESULTS: Mean age was 45 years (range 1 month to 83 years); 72% were males. Etiology was mainly endocarditis 32% (active 22%), congenital 31%, degenerative 9%, and aneurysm/dissection 12%. Twenty-seven percent underwent prior cardiac surgery. Hospital mortality was 5.5% (N=19). During follow-up (mean 7.4 years, maximum 18.5 years, 98% complete), 54 patients died; there were 57 valve-related reoperations (3 early technical, 11 non-structural, 39 structural valve deterioration (SVD), 4 endocarditis), 5 cerebrovascular accidents, 1 fatal bleeding, 8 endocarditis. Twelve-year cumulative survival was 71% (SE 3), freedom from reoperation for SVD 77% (SE 4); younger patient age was associated with increased SVD rates. Actual risk of allograft reoperation was comparable to porcine and pericardial bioprostheses in a simulated age-matched population. CONCLUSIONS: The use of allografts for AVR is associated with low occurrence rates of most valve-related events, but over time the risk of SVD increases, comparable to stented xenografts. It remains in our institute the preferred valve substitute only for patients with active aortic root endocarditis and for patients in whom anticoagulation should be avoided.
Johanna J M Takkenberg; Loes M A Klieverik; Jos A Bekkers; A Pieter Kappetein; Jolien W Roos; Marinus J C Eijkemans; Ad J J C Bogers
Related Documents :
12842517 - Current determinants of operative mortality in 1400 patients requiring aortic valve rep...
847417 - Cardiac valve replacement with the björk-shiley prosthesis in young patients.
19629887 - European contegra multicentre study: 7-year results after 165 valved bovine jugular vei...
1033047 - Current status of porcine heterograft prostheses: a 5-year appraisal.
17814827 - Destruction of pacific corals by the sea star acanthaster planci.
24402587 - Same-day synthetic osmotic dilators compared with overnight laminaria before abortion a...
Publication Detail:
Type:  Comparative Study; Journal Article     Date:  2007-03-12
Journal Detail:
Title:  European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery     Volume:  31     ISSN:  1010-7940     ISO Abbreviation:  Eur J Cardiothorac Surg     Publication Date:  2007 May 
Date Detail:
Created Date:  2007-04-09     Completed Date:  2007-07-19     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8804069     Medline TA:  Eur J Cardiothorac Surg     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  851-9     Citation Subset:  IM    
Department of Cardio-Thoracic Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aged, 80 and over
Aortic Valve / surgery*
Aortic Valve Insufficiency / mortality,  surgery
Aortic Valve Stenosis / mortality,  surgery
Child, Preschool
Follow-Up Studies
Heart Valve Prosthesis*
Heart Valve Prosthesis Implantation / methods,  mortality
Middle Aged
Postoperative Complications / etiology
Prospective Studies
Prosthesis Failure
Treatment Outcome

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effect of preoperative angiotensin converting enzyme inhibitor or angiotensin receptor blocker use o...
Next Document:  Rosuvastatin displays anti-atherothrombotic and anti-inflammatory properties in apoE-deficient mice.